Literature DB >> 15956941

Correction of large amblyopiogenic refractive errors in children using the excimer laser.

Lawrence Tychsen1, Eric Packwood, Gregg Berdy.   

Abstract

PURPOSE: We sought to determine whether laser subepithelial keratomileusis (LASEK) and photorefractive keratectomy (PRK) are effective methods for correcting amblyopiogenic refractive errors in children.
METHODS: Thirty-six eyes in 35 amblyopic children, who ranged in age from 4 to 16 years (mean, 8.4 years), received treatment for large magnitude ametropia. Seventy-two percent (25/35) of the children had a neurobehavioral disorder and/or were noncompliant with spectacle or contact lens wear. Myopia ranged from -3.25 to -24.25 D (mean, -11.48 D); one patient had hyperopia of +5.87 D. Correction was tailored to match the refractive error of the nonamblyopic eye. VISX Star S2/S3 excimer lasers were used in manual or auto-tracking modes, and corneal centration was achieved using brief, general anesthesia. Mean follow-up was 29.2 months (range, 4-42 months).
RESULTS: Myopia correction averaged -8.95 +/- 2.89 D (range, -3.25 to -15.50). Eighty-nine percent (31 children) were corrected to within +/- 1.00 D of goal refraction and the remaining 11% to within 2.0 D of the goal (most were undercorrected). Acuity improved postoperatively in 97%; by 1 optotype line in 37% and by 2 or more in 60%. No child lost acuity. Binocularity improved in 69% (24/35) and remained the same in 31%. Corneal haze measured grade 0-1 in 78%, grade 2 in 14%, and grade 3-4 in 8%. Myopic regression exceeding congruent with 1.0 D/year (0.08 D/month) occurred in 50% (18/36) of eyes treated. No substantial differences were observed in PRK- (n = 18) versus LASEK- (n = 17) treated children.
CONCLUSIONS: Laser refractive surgery is effective for correcting anisometropic myopia in amblyopic children. Recurrence of myopia is common. Further study is indicated to determine long-term stability and safety of the procedure in this population.

Entities:  

Mesh:

Year:  2005        PMID: 15956941     DOI: 10.1016/j.jaapos.2005.01.006

Source DB:  PubMed          Journal:  J AAPOS        ISSN: 1091-8531            Impact factor:   1.220


  11 in total

1.  Acute hydrops with secondary bacterial keratitis: sequelae of paediatric refractive surgery.

Authors:  Pooja Bandivadekar; Namrata Sharma; Ganesh Pillai; Tushar Agarwal; Jeewan S Titiyal
Journal:  Int Ophthalmol       Date:  2014-09-05       Impact factor: 2.031

2.  [TransPRK in general anesthesia-An alternative for anxious patients].

Authors:  Dennis von Rüden; Diego de Ortueta
Journal:  Ophthalmologie       Date:  2022-07-27

3.  Refractive Surgery for Special-Needs Children with High Myopia.

Authors:  Lawrence Tychsen
Journal:  Mo Med       Date:  2022 Jan-Feb

Review 4.  Myopia: Mechanisms and Strategies to Slow Down Its Progression.

Authors:  Andrea Russo; Alessandro Boldini; Davide Romano; Giuseppina Mazza; Stefano Bignotti; Francesco Morescalchi; Francesco Semeraro
Journal:  J Ophthalmol       Date:  2022-06-14       Impact factor: 1.974

5.  Current concepts in the management of amblyopia.

Authors:  Blanca Ruiz de Zárate; Jaime Tejedor
Journal:  Clin Ophthalmol       Date:  2007-12

6.  Laser in situ keratomileusis for treated myopic anisometropic amblyopia in children.

Authors:  Assad A Ghanem; Ashraf I Moad; Ehab H Nematallah; Ibrahim T El-Adawy; Ghada M Anwar
Journal:  Saudi J Ophthalmol       Date:  2010-01-12

7.  Pediatric refractive surgery in evolution.

Authors:  Jonathan Song; Ismael Al-Ghamdi; Abdulaziz Awad
Journal:  Middle East Afr J Ophthalmol       Date:  2012-01

8.  Bilateral myopic photorefractive keratectomy in a 14-year-old boy.

Authors:  Italo Giuffrè
Journal:  N Am J Med Sci       Date:  2010-01

9.  Orthoptic Changes following Photorefractive Keratectomy.

Authors:  Zhale Rajavi; Nader Nassiri; Monir Azizzadeh; Alireza Ramezani; Mehdi Yaseri
Journal:  J Ophthalmic Vis Res       Date:  2011-04

Review 10.  How to help children with neurodevelopmental and visual problems: a scoping review.

Authors:  C Williams; K Northstone; C Borwick; M Gainsborough; J Roe; S Howard; S Rogers; J Amos; J M Woodhouse
Journal:  Br J Ophthalmol       Date:  2013-10-24       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.